LivingGLP1
Study S001111

Safety and Effectiveness of Tirzepatide(Spartina )in Chronic Kidney Failure a Single-center Study

Registration

Registration
NCT07176663
Acronym
Tirzepatide
Study type
INTERVENTIONAL
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
15
Start
2026-02-01
Primary completion
2026-04-01
Lead sponsor
Shahid Beheshti University of Medical Sciences
Conditions
Obesity
Interventions
DRUG:Tirzepatide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • weight loss [kilogram of weight loss measured by same scale one and three month after injection]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.